Health Care

Broker Outlook For The Week Ahead CytomX Therapeutics, Inc. (NASDAQ:CTMX)

(NASDAQ:CTMX) have shifted north recently, touching a new 52-week high. The Director now owns $5,564,424 of the stock according to the SEC filing. Finally, Redmile Group LLC increased its holdings in CytomX Therapeutics by 2.4% during the second quarter. The value of the company's investment in CytomX Therapeutics, Inc. decreased from $1,311,000 to $1,293,000 decreasing 1.4% quarter over quarter. First Quadrant L P CA bought a new stake in CytomX Therapeutics during the second quarter valued at approximately $160,000. Goldman Sachs Group Inc. acquired a new stake in CytomX Therapeutics during the first quarter worth about $190,000. Finally, Voya Investment Management LLC purchased a new stake in shares of CytomX Therapeutics during the second quarter worth approximately $203,000. Wells Fargo & Company MN now owns 22,424 shares of the biotechnology company's stock worth $387,000 after acquiring an additional 7,747 shares in the last quarter.

Several equities research analysts recently weighed in on CTMX shares. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Cann restated a "hold" rating on shares of CytomX Therapeutics in a report on Tuesday, August 8th.

Current levels places CytomX Therapeutics, Inc.

In related news, major shareholder Kevin P. Starr sold 28,357 shares of the firm's stock in a transaction that occurred on Wednesday, April 12th. BidaskClub upgraded shares of CytomX Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday, July 8th. In response, Wedbush and Nomura raised their price targets on CTMX stock to $37 and to $44, respectively. Trading volume was up 174.36% over the stocks average daily volume.

If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & global trademark and copyright law. If you are reading this report on another site, it was illegally copied and republished in violation of global copyright and trademark legislation. The stock of CytomX Therapeutics Inc (NASDAQ:CTMX) earned "Hold" rating by Oppenheimer on Tuesday, August 8.

Shares of CytomX Therapeutics, Inc. Through this figure traders can analyze that CTMX show whether or not a stock now most active and standing in buying side or sell side.

The company is trading up by 15.00% percent from yesterday's close. The stock's market capitalization is $700.47 million. CytomX Therapeutics, Inc. The stock has a 50 day moving average of $16.66 and a 200 day moving average of $15.57.

CytomX Therapeutics (NASDAQ:CTMX) last issued its earnings results on Monday, August 7th.

Investors wait CytomX Therapeutics Inc (NASDAQ:CTMX) to report on November, 2. its quarterly earnings Wall Street analysts expect $-0.10 EPS, up $0.30 or 75.00 % from last year's $-0.4 same quarter earnings. CytomX Therapeutics had a negative net margin of 523.78% and a negative return on equity of 52.50%. Next quarter's EPS is estimated at $-0.43 with next year's EPS anticipated to be $-1.51. The shares were sold on September 1st for an average price of $17.32. Opaleye Management Inc. owns 460,000 shares valued at $7,130,000. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Robert C. Goeltz II sold 21,517 shares of the firm's stock in a transaction that occurred on Monday, March 20th. Insiders sold a total of 63,467 shares of company stock worth $1,098,858 in the last quarter. Following the completion of the transaction, the insider now directly owns 9,026 shares in the company, valued at $135,390. The disclosure for this sale can be found here. Over the past month the firm's stock is 7.89%, 17.65% for the last quarter, 8.32% for the past six-months and 22.42% for the a year ago.

CytomX Therapeutics, Inc is a clinical-stage, oncology-focused biopharmaceutical company. The Firm uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets.



Like this

loading...
loading...

Latest


05 October 2017
The Las Vegas Sands Corp.'s (LVS) "Buy" Rating Reaffirmed at CLSA
Finally, Arrowpoint Asset Management LLC raised its position in shares of Las Vegas Sands Corp .by 39.8% in the fourth quarter. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite.

05 October 2017
Putin does not exclude extension of global oil output cut deal
Growing US shale output means the market could return to surplus again next year if the producers were to reverse their curbs. If OPEC member countries agree on a further extension of the deal , it would be "at least until the end of 2018", Putin said.

05 October 2017
A Look Into the Returns of EnLink Midstream Partners, LP (NYSE:ENLK)
The stock of Enable Midstream Partners LP (NYSE:ENBL) has "Hold" rating given on Sunday, August 13 by RBC Capital Markets. Magellan Midstream Partners L.P. had 50 analyst reports since August 7, 2015 according to SRatingsIntel.

05 October 2017
Watching Shares of Navios Maritime Midstream Partn (NAP) — Technical Focus
Presently, Navios Maritime Midstream Partn (NAP)'s Williams Percent Range or 14 day Williams %R is resting at -27.27. Equities analysts expect that Navios Maritime Acquisition Corporation will post ($0.04) EPS for the current year.

05 October 2017
Apple releases watchOS 4.0.1 to fix cellular issues
Apple is also now in the process of beta testing watchOS 4.1, which will likely be released later this year to the public. watchOS 4.0.1 fixes a problem many ran into when reviewing the Apple Watch Series 3 before its release: connectivity.

05 October 2017
Winnebago Industries, Inc. (NYSE:WGO) Signals 'Overbought' Based on Its RSI
Price T Rowe Associate Incorporated Md holds 0% of its portfolio in Winnebago Industries, Inc . (NYSE:WGO) for 1,986 shares. Investors might also notice that two months ago the Buy recommendations (1) outnumbered Sell recommendations (0).

05 October 2017
Steelers support Puerto Rico relief efforts
Café Sbisa will donate 100 percent of the proceeds from their October sales to the Hurricane Maria recovery effort. Maria, a Category 4 hurricane, struck Puerto Rico on September 20, shortly after Hurricane Harvey and Irma.

05 October 2017
Ireland taken to court over not claiming Apple tax
It added the EC's decision was "extremely regrettable, especially in relation to a case with such a large scale recovery amount". Ireland had appealed the decision, but was still under deadline to comply with the order.

05 October 2017
White House cybersecurity coordinator calls Social Security identification system 'flawed'
Joyce has reportedly raised the issue of ditching Social Security numbers with the Trump administration. The comments came as former Equifax CEO Richard Smith testified to Congress today about the breach.

05 October 2017
Demi Lovato has sparked speculation she had feelings for Nick Jonas
But in case you haven't heard the song, in this particular case, " ruining the friendship " isn't a bad thing. This guy just treated me really poorly, and was playing games the whole time".